Stocks · Health care · Biological Products, (No Diagnostic Substances)

Acumen Pharmaceuticals, Inc.

ABOS Clue Score27
United States Fiscal year ends December CIK 0001576885 Results filed 26 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Matt Zuga
29 Dec 2022
CFO and Chief Business Officer
Exercised, kept
50,000
$1.19
$59.50K
Daniel Joseph OConnell
30 Nov 2021
President and CEO
Exercised, kept
1,118
$4.47
$5.00K
Daniel Joseph OConnell
6 Jul 2021
President and CEO
Exercised, kept
35
$4.47
$156.45

What was left out

Form 4 filings counted 120
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 8
Sales at will 42
Transactions with no price 0
Shares from compensation/vesting 30,618,063
History held since 2 Jul 2021